Clinical Characteristics, Anti-hyperglycaemic Treatment Pattern and Target Attainment of Type 2 Diabetes Mellitus Patients in Older Population With or Without Albuminuria in China
- Registration Number
- NCT03064841
- Lead Sponsor
- Boehringer Ingelheim
- Brief Summary
This is a multi-centre, cross-sectional, non-interventional study assessing blood glucose target attainment, anti-hyperglycaemic treatment pattern and the clinical characteristics in older outpatients with Type 2 Diabetes Mellitus (T2DM) in hospitals of China. This study is designed to collect information of older T2DM patients in a real life setting
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1537
Not provided
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Outpatient with confirmed T2DM No Treatment subjects with confirmed T2DM
- Primary Outcome Measures
Name Time Method Percentage of Patients Attained Blood Glucose Control Target Defined as Glycated Haemoglobin A1c (HbA1c)<7%, According to 2015 American Diabetes Association (ADA) and 2013 Chinese Diabetes Society (CDS) Guidelines. At study visit (one day) The percentage of patients attaining blood glucose control target defined as HbA1c\<7%, according to 2015 American Diabetes Association (ADA) and 2013 Chinese Diabetes Society (CDS) guidelines.
- Secondary Outcome Measures
Name Time Method Renal Function Level of Patients Measured by Estimated Glomerular Filtration Rate (eGFR) At study visit (one day) The renal function level of patients was measured by estimated glomerular filtration rate (eGFR).
Renal Function Level of Patients Measured by Albuminuria At study visit (one day) The renal function level of patients was measured by albuminuria into following categories - normal, micro-albuminuria, macro-albuminuria and missing data.
Albuminuria was measured using either as a random spot urine sample, a 24-h urine sample, or a timed urine sample. Normal was defined as \< 30 mg/g, \<30 mg/24h, and \< 20 μg/min with the random spot urine sample, the 24-h urine sample, and the timed urine sample, respectively. Micro-albuminuria was defined as 30 - 300 mg/g, 30 - 300 mg/24h, and 20 - 200 μg/min with the random spot urine sample, the 24-h urine sample, and the timed urine sample, respectively. Macro-albuminuria was defined as \>300 mg/g, \>300 mg/24h, and \>200 μg/min with the random spot urine sample, the 24-h urine sample, and the timed urine sample, respectively.Percentage of Patients With Lipid Lowering Therapy Usage At study visit (one day) The percentage of patients with lipid lowering therapy usage.
Renal Function Level of Patients Measured by Chronic Kidney Disease (CKD) Stage At study visit (one day) The renal function level of patients was measured by CKD into following categories - eGFR ≥ 60 milliLitre/minute/1.73 meter \^ 2 (mL/min/1.73m\^2), eGFR \< 60 mL/min/1.73m\^2 and missing data.
Treatment Regimens for T2DM That Patient Are Currently Taking At study visit (one day) The treatment regimens for T2DM that patient are currently taking.
Percentage of Patients Macro-vascular and Micro-vascular Diabetic Complications At study visit (one day) The percentage of patients macro-vascular and micro-vascular diabetic complications.
Percentage of Patients With Hypoglycaemic Occurrence At study visit (one day) The percentage of patients with hypoglycaemic occurrence.
Percentage of Patients With Hypoglycaemia Leading to Therapy Change At study visit (one day) The percentage of patients with hypoglycaemia leading to therapy change.
Follow up Duration of Type 2 Diabetes Related Risk Factors in Clinical Practice At study visit (one day) The follow up duration of type 2 diabetes related risk factors was summarized using the situation of lab test including serum creatinine, uric acid, high density lipoprotein cholesterol, low density lipoprotein cholesterol, triglyceride and total cholesterol.
Percentage of Patients With Anti-hypertension Therapy Usage At study visit (one day) The percentage of patients with anti-hypertension therapy usage.
Percentage of Patients With Anti-platelet Therapy Usage At study visit (one day) The percentage of patients with anti-platelet therapy usage.
Trial Locations
- Locations (18)
Beijing Hospital
🇨🇳Beijing, China
West China Hospital
🇨🇳Chengdu, China
The First Affiliated Hospital of Anhui Medical University
🇨🇳Hefei, China
Nanjing First Hospital
🇨🇳Nanjing, China
The affiliated hospital of medicalcollege qingdao university
🇨🇳Qingdao, China
Peking University Shougang Hospital
🇨🇳Beijing, China
Beijing Pinggu Hospital
🇨🇳Beijing, China
China Meitan General Hospital
🇨🇳Beijing, China
First Hospital of Jilin University
🇨🇳Changchun, China
Chinese Traditional Medicine Hospital of Sichuna Provinc
🇨🇳Chengdu, China
The First Affiliated Hospital of Henan University of Science and Technology
🇨🇳Luoyang, China
First Affiliated Hospital of Dalian Medical University
🇨🇳Dalian, China
Forth Clinical Hospital of Harbin Medical University
🇨🇳Harbin, China
Affiliated Hospital of Nantong University
🇨🇳Nantong, China
Shengjing Hospital of China Medical University
🇨🇳Shenyang, China
Shenzhen People's Hospital
🇨🇳Shenzhen, China
The First Affiliated Hospital of Soochow University
🇨🇳Suzhou, China
Integrated Chinese and Western Medicine Hospital
🇨🇳Nanjing, China